and Duramed Pharmaceuticals, Inc., engages in the development, manufacture, and marketing of pharmaceutical products.
It operates in two segments Generic Pharmaceuticals and Proprietary Pharmaceuticals.
Generic Pharmaceuticals segment provides approximately 100 dosage forms and strengths of approximately 70 different generic pharmaceutical products, including 19 oral contraceptive products, representing the category of its generic portfolio.
Proprietary Pharmaceuticals segment offers 11 proprietary pharmaceutical products, focusing in the female healthcare arena.
These products include SEASONALE, extended-cycle oral contraceptive product; Cenestin, line of hormone therapy products; and Plan B, emergency contraceptive product.
The company manufactures its products in the form of tablets, capsules, and powder.
Barr Pharmaceuticals market its products to drug store chains, supermarket chains, mass merchandisers, wholesalers, distributors, managed care organizations, mail order accounts, government/military, and repackagers in the United States and Puerto Rico.
The company was founded by Edwin A.
Cohen in 1970.
It was formerly known as Barr Laboratories, Inc.
and changed its name to Barr Pharmaceuticals, Inc.
in 2003.
Barr Pharmaceuticals is headquartered in Pomona, New York.
